Respiratory transfusion reactions
Abstract
Respiratory transfusion-related reactions are not very frequent, partly also because recognition and reporting transfusion reactions is still underemphasized. Tis article describes the most important respiratory transfusion reactions, their pathophysiology, clinical picture and treatment strategies. Respiratory transfusion related reactions can be primary or secondary. The most important primary transfusion-related reactions are TRALI - transfusion-related acute lung injury, TACO – transfusion-associated circulatory overload, and TAD - transfusion-associated dyspnea. TRALI is immuneassociated injury of alveolar basal membrane, which becomes highly permeable and causes noncardiogenic pulmonary edema. Treatment of TRALI is mainly supportive with oxygen, fluids (in case of hypotension) and in cases of severe acute respiratory failure also mechanic ventilation. TACO is caused by volume overload in predisposed individuals, such as patients with heart failure, the elderly, infants, patients with anemia and patients with positive fluid balance. Clinical picture is that of a typical pulmonary cardiogenic edema, and the therapy is classical: oxygen and diuretics, and in severe cases also non-invasive or invasive mechanical ventilation. TAD is usually a mild reaction of unknown cause and cannot be classified as TACO or TRALI, nor can it be ascribed to patient’s preexisting diseases. Although the transfusion-related reactions are not very common, knowledge about them can prevent serious consequences. On the one hand preventive measures should be sought, and on the other early recognition is beneficial, so that proper treatment can take place.
Downloads
References
Bricl I, Marić I. Hemovigilanca – poročilo 2013. Isis, Glasilo Zdravniške zbornice Slovenije. 2014;12:52–6.
Bricl I, Marić I. Hemovigilanca – poročilo 2014. Isis, Glasilo Zdravniške zbornice Slovenije. 2015;7:56–61.
Bux J, Sashs UJH. Pulmonary Transfusion Reactions. Transfusion Medicine and Hemotherapy 2008;35(5):337–45.
Callum J, Lin Y, Pinkerton PH, Karkouti K, Pendergast JM, Robitaille N, et al. Bloody easy 3. 3rd edition. Ontario: Orbcon; 2011. p. 34
Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): A clinical review with emphasis on the critically ill. Br. J haematology 2009;147(4):431–43.
Mazzei CA, Popovsky MA, Kopko PM. Noninfectious Complications of Blood Transfusion. In: Fung MK, Grossman JB, Hillyer CD, Westhoff CM ur. Technical manual. 18th ed. Bethesda, Maryland: AABB; 2014. p. 665–96.
Nakagawa M, Toy P. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: Cases of one hospital. Transfusion 2004;44(12):1689–94.
Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6):573–7.
Kleinman S, Caulfeld T, Chan P, Davenport R, Mc-Farland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–89.
Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang. 2005;89(1):1–10
Popovsky MA, Haley NR. Further characterization of transfusion-related lung injury: Demographics, clinical and laboratory features, and morbidity. Immunohematology. 2000;16(4):157–9.
Silliman CC, Boshkov LK, Mehdizadehkashi Z. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454–62.
Wolf CFW, Canale VC. Fetal pulmonary hypersensitivity reaction to HLA incompatible blood transfusion: Report of a case and review of the literature. Transfusion. 1976;16(2):135–40.
Kopko PM, Popovsky MA, MacKenzie MR. Human leukocyte antigen class II antibodies in transfusion- related acute lung injury. Transfusion. 2001;41(10):1244–8.
Kopko PM, Paglirioni TG, Popovsky MA. TRALI: Correlation of antigen-antibody and monocytes activation in donor-recipient pairs. Transfusion. 2003;43(2):177–84.
Davoren A, Curtis BR, Shulman IA. TRALI duo to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma. A report of 2 fatalite. Transfusion. 2003;43(5):641–5.
Bux J, Becker F, Seeger W. Transfusion-related acute lung injury due to HLA A2-specifc antibodies in donor blood. Br J Haematol. 1996, 93(3):707–13.
Eastlund DT, McGraht PC, Burkart P. Platelet transfusion reaction associated with interdonor HLA incompatibility. Vox Sang. 1988;55(3):157–60.
Silliman CC, Turman GW, Abruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating factor receptor. Vox Sang. 1992;63(2):133–6.
Silliman CC, Paterson AJ, Dickey DF. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion. 1997;37(7):719–26.
Silliman CC, Voelkel NF, Allard JD. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101(7):1458–67.
Andrews AT, Zmijewski CM, Bowman HS, Reinhart JK. Transfusion reaction with pulmonary infiltration associated with HLA specific leukocyte antibodies. Am j Clin Pathol. 1976;66:483–7.
Milojković A, Cukjati M. Inaktivacija patogenov v krvnih komponentah: tehnologije, trenutno v uporabi, in trendi v prihodnosti. Zdrav Vestn. Supl. 2012;81:II-281–90.
Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012;52(1):160–5.
Menis M, Anderson SA, Forshee RA, McKean S, Johnson C, Holness L, et al. Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang. 2014;106(2):144–52.
Popovsky MA, Audet AM, Andrzejewski C. transfusion-associated circulatory overload in orthopedic surgery patients: A multi-institutional study. Immunihematology. 1996;12(2):87–9.
Andrzejewski C, Popovsky MA. Transfusion-associated adverse pulmonary swquelae: Widening our perspective. Transfusion. 2005;45(7):1048–50.
Zhou L, Giacherion D, Cooling L, Davenport RD. Use of B-natriuretic peptides as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion. 2005;45(7):1056–63.
Marriott HL, Kekwick A. Volume and rate in blood transfusion for the relief of anaemia. Br Med J. 1940;1:1043–6.
Squires JE. Risks of transfusion. South Med J. 2011;104(11):762–9.
Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol. 2012;159(2):143–53.
Skeate RC, Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol. 2007;14(6):682–7.
Bernard GR, Artigas A, Brigham KL, Carlet J, Fallke K, Lamy M, et al. Te American-European Consensus Conference on ARDS: defnitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3):818–24.
Abraham E, Matthay MA, Dinarello CA, Charles A, Vincent JL, Cohen J,et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med. 2000;28(1):232–5.
Meade MO, Guyatt GH, Cook RJ, et al. Agreement between alternative classifications of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;163(2):490–3.
Kim B, Downing J, King S, Badami KS. Transfusions, troubled breathing, and transient neutropenia. Pathology. 2015;47(7):714–6.
Ray P, Lefort Y. Usefulness of B-type natriuretic peptide in emergency medicine. Rev Med Interne. 2006(11):858–64.
Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion- associated circulatory overload from transfusion-related acute lung injury. Crit Care Med; 34(5):109–13.
Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004;126(1):249–58.
Stack G, Judge JV, Snyder EL. Febrile and non-immune transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA, ur. Principles of Transfusion Medicine. Baltimore: Williams & Wilkins; 1996. p. 773–84.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;37(27):2129–200.
Tseng E, Spradbrow J, Cao X, Callum J, Lin Y. An order set and checklist improve physician transfusion ordering practices to mitigate the risk of transfusion-associated circulatory overload. Transfus Med. 2016;26(2):104–10.
Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood Banking and Transfusion Medicine. Basic Principles and Practice. 2. Churchill Livingstone Elsevier; 2007. p. 678–9.
Toy P, Gajic O. Transfusion-related acute lung injury. Anesth Analg. 2004;99(6):1623–4.
Moore SB. Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. Crit Care Med. 2006;34(5):114–7.
Copyright (c) 2017 Slovenian Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
